利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

64 条记录 (耗时 0.022 秒)

    FLUORINATED ORGANOSILICON COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
    7.
    发明公开
    FLUORINATED ORGANOSILICON COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF 失效
    佛罗伦萨有色金属公司ZU IHRER HERSTELLUNG

    公开(公告)号：EP0928803A1

    公开(公告)日：1999-07-14

    申请号：EP97930797.2

    申请日：1997-07-15

    申请人： ASAHI GLASS COMPANY LTD. ,  OSi Specialties, Inc.

    发明人： FURUKAWA, Yutaka ,  KOTERA, Mami ,  KUMAI, Seisaku ,  RUCKLE, Robert, E., Jr. ,  MURPHY, Gerald, J.

    IPC分类号： C08G77/16 ,  C08G77/24 ,  C08G77/46

    CPC分类号： C08G77/385 ,  C08G77/24 ,  C08G77/46

    摘要： A fluorine-containing organic silicon compound represented by the following formula 1, which is useful as various industrial base materials required to have performances such as water and oil repellency, anti-fouling properties or release properties and as raw materials therefor. Here, A f represents a specific polyfluorohydrocarbon group-containing organic group; R 1 and R 2 which are independent of each other, represent bivalent organic groups; R 3 to R 9 which are independent of one another, represent monovalent organic groups; a is an integer of at least 1, and b is an integer of at least 0:

    摘要翻译： 由下式1表示的含氟有机硅化合物，其可用作具有防水拒油性，防污性或脱模性等性能的各种工业基材，作为其原料。 这里，A 表示具体的含多氟烃基的有机基团; R 1和R 2彼此独立地表示二价有机基团; R 3至R 9彼此独立地表示一价有机基团; a是至少为1的整数，b是至少为0的整数：

    TECHNETIUM-99m GENERATOR SYSTEM
    8.
    发明公开
    TECHNETIUM-99m GENERATOR SYSTEM 失效
    方法锝-99m生产

    公开(公告)号：EP0912218A1

    公开(公告)日：1999-05-06

    申请号：EP96945953.0

    申请日：1996-12-12

    申请人： LOCKHEED MARTIN ENERGY SYSTEMS, INC.

    发明人： MIRZADEH, Saed ,  KNAPP, Furn, F., Jr. ,  COLLINS, Emory, D.

    IPC分类号： G21G4 ,  A61K51 ,  B01D15 ,  B01D59 ,  B01J41 ,  C01G99 ,  C07F13

    CPC分类号： A61K51/1282 ,  G21G2001/0036

    摘要： A ?99Mo/99m¿Tc generator system includes a sorbent column (11) loaded with a composition containing 99Mo. The sorbent column (11) has an effluent end (31) in fluid communication with an anion-exchange column (15) for concentrating 99mTc eluted from the sorbent column (11). A method of preparing a concentrated solution of 99mTc includes the general steps of a) providing a sorbent column (11) loaded with a composition containing 99Mo, the sorbent column having an effluent end (31) in fluid communication with an anion-exchange column (15); b) eluting the sorbent column (11) with a salt solution to elute 99mTc from the sorbent and to trap and concentrate the eluted 99mTc on the anion-exchange column; and c) eluting the concentrated 99mTc from the anion-exchange column with a solution comprising a reductive complexing agent.

    THREE-PHASE PHARMACEUTICAL FORM WITH CONSTANT AND CONTROLLED RELEASE OF AMORPHOUS ACTIVE INGREDIENT FOR SINGLE DAILY APPLICATION
    9.
    发明公开
    THREE-PHASE PHARMACEUTICAL FORM WITH CONSTANT AND CONTROLLED RELEASE OF AMORPHOUS ACTIVE INGREDIENT FOR SINGLE DAILY APPLICATION 失效
    三相药物剂型常数和一次性日无定形物质形式的控释

    公开(公告)号：EP0827397A2

    公开(公告)日：1998-03-11

    申请号：EP96915292.0

    申请日：1996-05-17

    申请人： Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.D.

    发明人： KERC, Janez ,  REBIC, Ljubomira, Barbara ,  KOFLER, Bojan

    IPC分类号： A61K9 ,  A61K31 ,  A61K45 ,  A61K47 ,  A61P9

    CPC分类号： A61K9/2077 ,  A61K9/2846 ,  A61K9/2866 ,  A61K9/2886

    摘要： Described is a novel three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient stabilized with polymers for a single daily peroral application, which is especially suitable for active ingredients existing in amorphous form or in one or more polymorphous forms, which exhibit poor solubility in crystal form depending on the polymorphous form, particle size and the specific surface area of the active ingredient. The active ingredient can be used in its amorphous or any polymorphous form, which in the process of the preparation of the three-phase pharmaceutical form according to the invention is converted into the amorphous form. The three-phase pharmaceutical form with constant and controlled release of an amorphous active ingredient for a single daily peroral application contains a core consisting of a first and a second phase and a coating representing the third phase. In the first phase the three-phase pharmaceutical form contains an amorphous active ingredient, the water-soluble polymer polyvinylpyrrolidone and a cellulose ether as carriers of the amorphous active ingredient and simultaneously as inhibitors of its crystallization, a surfactant that improves the solubility of the active ingredient and promotes the absorption of the amorphous active ingredient from gastrointestinal tract, in the second phase it contains a cellulose ether and a mixture of mono-, di- and triglycerides as sustained release agents and the third phase is represented by a poorly soluble or gastro-resistant film coating, which in the first few hours after the application controls the release of the active ingredient and can consist of an ester of hydroxypropylmethylcellulose with phthalic anhydride or of a copolymerizate based on methacrylic acid and ethyl acrylate. Described is also a process for the preparation of this pharmaceutical form.

    ELECTROLYTIC CELL AND ELECTROLYTIC PROCESS
    10.
    发明授权
    ELECTROLYTIC CELL AND ELECTROLYTIC PROCESS 失效
    电解池电解法

    公开(公告)号：EP0797846B1

    公开(公告)日：2004-03-03

    申请号：EP96936336.5

    申请日：1996-10-11

    申请人： Hirion Electrochemical. Inc.

    发明人： SHI, Jie ,  MASSUCCO, Arthur, A. ,  FAUTEUX, Denis, G.

    IPC分类号： H01M4/02

    CPC分类号： H01M4/664 ,  H01M4/66

    摘要： An electrolytic cell (10) having an electrolyte (30), a first and second electrode (11, 12) and a primer (20, 40) comprised of lithium polysilicate and carbon, applied to at least one of the first and second electrodes (11, 12), wherein the primer (20, 40) is chemically and electrochemically stable and electronically conductive so as to decrease interfacial resistance in the cell to enhance columbic efficiency.